Aurinia Pharmaceuticals financial statements

오리니아 파머슈티컬스NASDAQ:AUPH · Nasdaq · Healthcare
$15.83-0.75%
2026-10-02 close

Aurinia Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $235M. 2024 operating profit was −$5M.

Reported results

Aurinia Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q